Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Identification of cortical lesions using DIR and FLAIR in early stages of multiple sclerosis.
Default Network Connectivity Is Linked to Memory Status in Multiple Sclerosis.
The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis.
Persistence and pathogenesis of the neurotropic polyomavirus JC.
Molecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and disease.
Rituximab treatment did not aggravate ongoing progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
Differential Sox10 genomic occupancy in myelinating glia.
The Ifng Gene Is Essential for Vdr Gene Expression and Vitamin D3-Mediated Reduction of the Pathogenic T Cell Burden in the Central Nervous System in Experimental Autoimmune Encephalomyelitis, a Multiple Sclerosis Model.
Telehealth weight management intervention for adults with physical disabilities: a randomized controlled trial.
The role of Ets2 transcription factor in the induction of microRNA-155 by LPS, and its targeting by IL-10.
Myelin damage and repair in pathologic CNS: challenges and prospects.
Female sexual dysfunction in multiple sclerosis: Results of a survey among Dutch urologists and patients.
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array.
The number of optic neuritis attacks is a potential confounder when comparing patients with NMO vs. controls by voxel-based neuroimaging analysis.
Opportunistic DNA Recombination with Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence.
The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.
Cytokine-Regulated Neutrophil Recruitment Is Required for Brain but Not Spinal Cord Inflammation during Experimental Autoimmune Encephalomyelitis.
Dendritic Cells and Anergic Type I NKT Cells Play a Crucial Role in Sulfatide-Mediated Immune Regulation in Experimental Autoimmune Encephalomyelitis.
[Regarding the article: "multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort"].
Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis.
Influence of Personality on the Relationship Between Gray Matter Volume and Neuropsychiatric Symptoms in Multiple Sclerosis.
Successful trabeculotomy in a patient with corticosteroid-induced glaucoma with anti-aquaporin 4 antibody-positive neuromyelitis optica: a case report.
Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies.
Pages
« first
‹ previous
…
442
443
444
445
446
447
448
449
450
…
next ›
last »